All In Biotech

Drug Trial Radar · NCT00066703

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

A Phase III Trial Evaluating The Role Of Exemestane Plus GnRH Analogue As Adjuvant Therapy For Premenopausal Women With Endocrine Responsive Breast Cancer

Last checked: Nov 19, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,672 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,672

Actual

Start

Nov 3, 2003

Primary completion

Mar 11, 2011

Study completion Oct 23, 2024

Sponsor

Lead sponsor
ETOP IBCSG Partners FoundationResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); Breast International Group
First posted
Aug 7, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using triptorelin, exemestane, and tamoxifen may fight breast cancer by blocking the use of estrogen. It is not yet known whether giving triptorelin together with exemestane is more effective than triptorelin and tamoxifen in treating hormone-responsive breast cancer. PURPOSE: This randomized phase III trial is studying triptorelin and exemestane to see how well they work compared to triptorelin and tamoxifen in treating premenopausal women with hormone-responsive breast cancer.

Conditions

  • Breast Cancer

Interventions

  • exemestaneDrug

  • tamoxifenDrug

  • triptorelinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free SurvivalTime frame: 5-year estimate reported at a median follow-up of 72 months

Locations

228 sites in 17 countries. Site status is shown where the registry gives one.

  • Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center

    Burbank, California

  • Rebecca and John Moores UCSD Cancer Center

    La Jolla, California

  • Providence Holy Cross Cancer Center

    Mission Hills, California

  • Desert Regional Medical Center Comprehensive Cancer Center

    Palm Springs, California

  • Sutter Cancer Center at Roseville Medical Center

    Roseville, California

  • Sutter Cancer Center

    Sacramento, California

  • Mercy General Hospital

    Sacramento, California

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California

  • Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital

    Whittier, California

  • University of Colorado Cancer Center at UC Health Sciences Center

    Aurora, Colorado

  • Shaw Regional Cancer Center

    Edwards, Colorado

  • Poudre Valley Hospital

    Fort Collins, Colorado

  • Front Range Cancer Specialists

    Fort Collins, Colorado

  • Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center

    Farmington, Connecticut

  • Sibley Memorial Hospital

    Washington D.C., District of Columbia

  • Walter Reed Army Medical Center

    Washington D.C., District of Columbia

  • Mayo Clinic - Jacksonville

    Jacksonville, Florida

  • Northeast Georgia Medical Center

    Gainesville, Georgia

  • Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Boise, Idaho

  • Kootenai Cancer Center - Coeur d'Alene

    Coeur d'Alene, Idaho

  • Resurrection Medical Center

    Chicago, Illinois

  • University of Chicago Cancer Research Center

    Chicago, Illinois

  • Decatur Memorial Hospital Cancer Care Institute

    Decatur, Illinois

  • Evanston Hospital

    Evanston, Illinois

  • CCOP - Carle Cancer Center

    Urbana, Illinois

  • Elkhart Clinic, LLC

    Elkhart, Indiana

  • Elkhart General Hospital

    Elkhart, Indiana

  • Fort Wayne Medical Oncology and Hematology

    Fort Wayne, Indiana

  • Howard Community Hospital

    Kokomo, Indiana

  • Center for Cancer Therapy at LaPorte Hospital and Health Services

    La Porte, Indiana

  • Saint Joseph Regional Medical Center

    Mishawaka, Indiana

  • CCOP - Northern Indiana CR Consortium

    South Bend, Indiana

  • Memorial Hospital of South Bend

    South Bend, Indiana

  • Michiana Hematology-Oncology, PC - South Bend

    South Bend, Indiana

  • South Bend Clinic

    South Bend, Indiana

  • Siouxland Hematology-Oncology Associates, LLP

    Sioux City, Iowa

  • Cancer Center of Kansas, PA - Chanute

    Chanute, Kansas

  • Cancer Center of Kansas, PA - Dodge City

    Dodge City, Kansas

  • Cancer Center of Kansas, PA - El Dorado

    El Dorado, Kansas

  • Cancer Center of Kansas-Independence

    Independence, Kansas

Showing 40 of 228 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.